These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33228820)

  • 1. Anthracycline-related acute cardiotoxicity in a very young Omani patient with acute myeloid leukaemia.
    Tony S; Mevada R; Joshi N
    Cardiol Young; 2021 Mar; 31(3):464-467. PubMed ID: 33228820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cardiomyopathy in acute myeloid leukemia patients treated with anthracyclines.
    Mort MK; Sen JM; Morris AL; DeGregory KA; McLoughlin EM; Mort JF; Dunn SP; Abuannadi M; Keng MK
    J Oncol Pharm Pract; 2020 Apr; 26(3):680-687. PubMed ID: 31500517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and predictors of anthracycline cardiotoxicity in children treated for acute myeloid leukaemia: retrospective cohort study in a single centre in the United Kingdom.
    Temming P; Qureshi A; Hardt J; Leiper AD; Levitt G; Ancliff PJ; Webb DK
    Pediatr Blood Cancer; 2011 Apr; 56(4):625-30. PubMed ID: 21298750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthracycline-Related Cardiotoxicity in Patients with Acute Myeloid Leukemia and Down Syndrome: A Literature Review.
    Hefti E; Blanco JG
    Cardiovasc Toxicol; 2016 Jan; 16(1):5-13. PubMed ID: 25616318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study.
    Linares Ballesteros A; Sanguino Lobo R; Villada Valencia JC; Arévalo Leal O; Plazas Hernández DC; Aponte Barrios N; Perdomo Ramírez I
    Colomb Med (Cali); 2021 Feb; 52(1):e2034542. PubMed ID: 33911320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of biomarkers and echocardiography in the evaluation of cardiotoxicity risk in children treated for leukemia.
    Raluca Maniu D; Blag C; Popa G; Bota M; Vlad C; Cainap C; Balacescu O; Pop L; Cainap SS
    J BUON; 2018 Dec; 23(7):122-131. PubMed ID: 30722121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac toxicity after anthracycline chemotherapy in childhood.
    Iarussi D; Indolfi P; Galderisi M; Bossone E
    Herz; 2000 Nov; 25(7):676-88. PubMed ID: 11141677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of dexrazoxane for clinical and subclinical cardiotoxicity in children with acute myeloid leukemia.
    Sánchez-Medina J; Gonzalez-Ramella O; Gallegos-Castorena S
    J Pediatr Hematol Oncol; 2010 May; 32(4):294-7. PubMed ID: 20404753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A strategy to reduce cumulative anthracycline exposure in low-risk pediatric acute myeloid leukemia while maintaining favorable outcomes.
    Sabnis HS; Minson KA; Monroe C; Allen K; Metts JL; Cooper TM; Woods WG; Castellino SM; Keller FG
    Leuk Res; 2020 Sep; 96():106421. PubMed ID: 32683126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients.
    Zhou X; Weng Y; Jiang T; Ou W; Zhang N; Dong Q; Tang X
    BMC Cancer; 2023 Oct; 23(1):976. PubMed ID: 37833648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimizing cardiac toxicity in children with acute myeloid leukemia.
    Narayan HK; Getz KD; Leger KJ
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):368-375. PubMed ID: 34889355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia. Analysis of the clinico-pathological aspects of documented acute anthracycline-induced cardiotoxicity in patients treated for acute leukaemia at the University Hospital of Zürich, Switzerland, between 1990 and 1996.
    Dazzi H; Kaufmann K; Follath F
    Ann Oncol; 2001 Jul; 12(7):963-6. PubMed ID: 11521803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disclosing an In-Frame Deletion of the Titin Gene as the Possible Predisposing Factor of Anthracycline-Induced Cardiomyopathy: A Case Report.
    Chang YW; Weng HY; Tsai SF; Fan FS
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML.
    Creutzig U; Diekamp S; Zimmermann M; Reinhardt D
    Pediatr Blood Cancer; 2007 Jun; 48(7):651-62. PubMed ID: 17183582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early cardiac outcomes following contemporary treatment for childhood acute myeloid leukemia: a North American perspective.
    Orgel E; Zung L; Ji L; Finklestein J; Feusner J; Freyer DR
    Pediatr Blood Cancer; 2013 Sep; 60(9):1528-33. PubMed ID: 23441080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe heart failure in consequence of late anthracycline-induced cardiotoxicity--case report].
    Urbanová D; Bubanská E; Hrebík M; Mladosievicová B
    Klin Onkol; 2009; 22(1):34-7. PubMed ID: 19534438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiotoxicity of anthracyclines].
    Costache II; Petriş A
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1200-7. PubMed ID: 22276470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal evaluation of anthracycline cardiotoxicity by signal-averaged electrocardiography in children with cancer.
    Fukumi D; Uchikoba Y; Maeda M; Ogawa S
    Pediatr Int; 2002 Apr; 44(2):134-40. PubMed ID: 11896869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report and review of the literature: the utilisation of a ventricular assist device as bridge to recovery for anthracycline-induced ventricular dysfunction.
    Krasnopero D; Asante-Korang A; Jacobs JP; Stapleton S; Carapellucci J; Dotson M; Stapleton G
    Cardiol Young; 2018 Mar; 28(3):471-475. PubMed ID: 29198224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric AML patients with acute-onset cardiomyopathy in the setting of Streptococcus viridans bacteremia after anthracyclines.
    Sabet K; Panigrahi A; Chung J; Dayan Y
    Pediatr Blood Cancer; 2022 Feb; 69(2):e29450. PubMed ID: 34854543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.